Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NIH Office of rDNA Activities Advisory Committee to be established after termination of RAC.

Executive Summary

NIH OFFICE OF rDNA ACTIVITIES PLANNING FOR GENE POLICY CONFERENCES as a means to ensure continued open discussion of gene therapy following the planned abolition of the National Institutes of Health Recombinant DNA Advisory Committee. ORDA envisions the conferences as two-day meetings, bringing ethicists, lawyers and public advisors together to discuss issues in gene therapy such as safety, in utero gene therapy, human subjects and vector development.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS028365

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel